National Institute for Health and Care Excellence. 2013 NICE Process and Methods Guides. Guide to the Methods of Technology Appraisal 2013. London: National Institute for Health and Care Excellence (NICE).
Shiroiwa, T. (2020). Cost-effectiveness evaluation for pricing medicines and devices: A new value-based price adjustment system in Japan. International journal of technology assessment in health care, 36(3), 270–276.
Center for Outcomes Research and Economic Evaluation for Health. 2022 Guideline for Preparing Cost-Effectiveness Evaluation to the Central Social Insurance Medical Council. Available from https://c2h.niph.go.jp/tools/guideline/guideline_en.pdf. accessed 10 Jan 2023
1990 EuroQol--a new facility for the measurement of health-related quality of life. Health policy (Amsterdam, Netherlands). 16(3):199–208
Shiroiwa, T., Fukuda, T., Ikeda, S., et al. (2016). Japanese population norms for preference-based measures: EQ-5D-3L, EQ-5D-5L, and SF-6D. Quality of life Research, 25(3), 707–719.
Feeny, D., Furlong, W., Torrance, G. W., et al. (2002). Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Medical care., 40(2), 113–128.
Noto, S., Shiroiwa, T., Kobayashi, M., Murata, T., Ikeda, S., & Fukuda, T. (2020). Development of a multiplicative, multi-attribute utility function and eight single-attribute utility functions for the Health Utilities Index Mark 3 in Japan. Journal of patient-reported outcomes., 4(1), 23.
Article PubMed PubMed Central Google Scholar
Brazier, J. E., Mulhern, B. J., Bjorner, J. B., et al. (2020). Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Medical care., 58(6), 557–565.
King, M. T., Costa, D. S., Aaronson, N. K., et al. (2016). QLU-C10D: A health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30. Quality of life research, 25(3), 625–636.
Article CAS PubMed Google Scholar
Norman, R., Viney, R., Aaronson, N. K., et al. (2016). Using a discrete choice experiment to value the QLU-C10D: Feasibility and sensitivity to presentation format. Quality of life Research, 25(3), 637–649.
Article CAS PubMed Google Scholar
Smith, A. B., Cocks, K., Parry, D., & Taylor, M. (2014). Reporting of health-related quality of life (HRQOL) data in oncology trials: A comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT-G). Quality of life Research, 23(3), 971–976.
McTaggart-Cowan, H., Teckle, P., & Peacock, S. (2013). Mapping utilities from cancer-specific health-related quality of life instruments: A review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research, 13(6), 753–765.
Xie, F., Pickard, A. S., & Krabbe, P. F. (2015). A checklist for reporting valuation studies of multi-attribute utility-based instruments (CREATE). PharmacoEconomics, 33(8), 867–877.
Article PubMed PubMed Central Google Scholar
Finch, A. P., Gamper, E., & Norman, R. (2021). Estimation of an EORTC QLU-C10 value set for spain using a discrete choice experiment. PharmacoEconomics, 39(9), 1085–1098.
Article PubMed PubMed Central Google Scholar
Gamper, E. M., King, M. T., Norman, R., et al. (2020). EORTC QLU-C10D value sets for Austria, Italy, and Poland. Quality of life Research, 29(9), 2485–2495.
Article CAS PubMed PubMed Central Google Scholar
Jansen, F., Verdonck-de Leeuw, I. M., & Gamper, E. (2021). Dutch utility weights for the EORTC cancer-specific utility instrument: The Dutch EORTC QLU-C10D. Quality of life Research, 30(7), 2009–2019.
Article PubMed PubMed Central Google Scholar
Kemmler, G., Gamper, E., & Nerich, V. (2019). German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30. Quality of life Research, 28(12), 3197–3211.
Article PubMed PubMed Central Google Scholar
King, M. T., Viney, R., & Simon Pickard, A. (2018). Australian utility weights for the EORTC QLU-C10D, a multi-attribute utility instrument derived from the cancer-specific quality of life questionnaire, EORTC QLQ-C30. PharmacoEconomics, 36(2), 225–238.
McTaggart-Cowan, H., King, M. T., Norman, R., et al. (2019). The EORTC QLU-C10D: The Canadian valuation study and algorithm to derive cancer-specific utilities from the EORTC QLQ-C30. MDM policy & practice, 4(1), 2381468319842532.
Nerich, V., Gamper, E. M., Norman, R., et al. (2021). French value-set of the QLU-C10D, a cancer-specific utility measure derived from the QLQ-C30. Applied health economics and health policy., 19(2), 191–202.
Norman, R., Mercieca-Bebber, R., & Rowen, D. (2019). UK utility weights for the EORTC QLU-C10D. Health Economics, 28(12), 1385–401.
Revicki, D. A., King, M. T., & Viney, R. (2021). United States utility algorithm for the EORTC QLU-C10D, a multiattribute utility instrument based on a cancer-specific quality-of-life instrument. Medical Decision Making, 41(4), 485–501.
Finch, A., Gamper, E., Norman, R., et al. (2021). Estimation of an EORTC QLU-C10D value set for Spain using a discrete choice experiment. PharmacoEconomics, 39, 1085–1098.
Article PubMed PubMed Central Google Scholar
Gamper, E. M., King, M. T., Norman, R., et al. (2020). EORTC QLU-C10D value sets for Austria, Italy, and Poland. Quality of Life Research, 29(9), 2485–2495.
Article CAS PubMed PubMed Central Google Scholar
Jansen, F., Verdonck-de Leeuw, I., Gamper, E., et al. (2021). Dutch utility weights for the EORTC cancer-specific utility instrument: The Dutch EORTC QLU-C10D. Quality of Life Research., 30, 2009–2019.
Article PubMed PubMed Central Google Scholar
Kemmler, G., King, M., Norman, R., Viney, R., Gamper, E., & Holzner, B. (2019). German value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30. Quality of Life Research Journal, Quality of Life Research, 28, 3197–3211.
Nerich, V., Gamper, E. M., Norman, R., et al. (2021). French value-set of the QLU-C10D, a cancer-specific utility measure derived from the QLQ-C30. Applied Health Economics and Health Policy, 19(2), 191–202.
Revicki, D. A., King, M. T., Viney, R., et al. (2021). United States utility algorithm for the EORTC QLU-C10D, a multiattribute utility instrument based on a cancer-specific quality-of-life instrument. Medical Decision Making, 41(4), 485–501.
ICC/ESOMAR. The International Code on Market, Opinion and Social Research and Data Analytics 2016 [Available from: https://iccwbo.org/publication/iccesomar-international-code-market-opinion-social-research-data-analytics/.
Shiroiwa, T., Noto, S., & Fukuda, T. (2021). Japanese population norms of EQ-5D-5L and health utilities index mark 3: disutility catalog by disease and symptom in community settings. Value Health, 24(8), 1193–1202.
Bansback, N., Brazier, J., Tsuchiya, A., & Anis, A. (2012). Using a discrete choice experiment to estimate societal health state utility values. Journal of Health Economics, 31, 306–318.
Lancsar, E., & Louviere, J. (2008). Conducting discrete choice experiments to inform healthcare decision making: A user’s guide. PharmacoEconomics, 26(8), 661–677.
Norman, R., Viney, R., & Brazier, J. (2014). Valuing SF-6D health states using a Discrete Choice Experiment. Medical Decision Making., 34(6), 773–786.
Viney, R., Norman, R., & Brazier, J. E. (2014). An Australian discrete choice experiment to value EQ-5D health states. Health Economics, 23(6), 729–742.
Mulhern, B., Norman, R., Street, D. J., & Viney, R. (2019). One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation. PharmacoEconomics, 37(1), 29–43.
de Bekker-Grob, E. W., Donkers, B., Jonker, M. F., & Stolk, E. A. (2015). Sample size requirements for discrete-choice experiments in healthcare: A practical guide. Patient, 8(5), 373–384.
Comments (0)